METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Clinical trials for METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE explained in plain language.
Never miss a new study
Get alerted when new METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE trials appear
Sign up with your email to follow new studies for METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Rice bran shows promise for fatty liver management
Disease control CompletedThis study looked at whether adding rice bran to nutrition education helps people with metabolic fatty liver disease. 58 overweight or obese adults with moderate fatty liver took part. They received nutrition education either alone or with rice bran supplements. The goal was to s…
Matched conditions: METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Phase: NA • Sponsor: Shih Chien University • Aim: Disease control
Last updated May 12, 2026 13:40 UTC
-
Massive study reveals hidden liver dangers in seniors
Knowledge-focused CompletedThis study looked at 10,000 elderly patients (age 60+) with fatty liver disease to find out what increases their risk for serious liver problems like scarring, cirrhosis, and liver cancer. Researchers collected health data over time and used computer models to predict who might d…
Matched conditions: METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Knowledge-focused
Last updated May 17, 2026 12:59 UTC
-
Digital liver score may predict who gets sick
Knowledge-focused CompletedThis study looked at 1,578 people with a type of fatty liver disease called MASLD. Researchers used a computer program to analyze liver biopsy images and calculate a score called Ph-FCS. The goal was to see if this score could predict who would later have serious liver complicati…
Matched conditions: METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Sponsor: PharmaNest, Inc • Aim: Knowledge-focused
Last updated May 14, 2026 12:06 UTC
-
Digital biopsy score may predict liver failure risk in MASLD patients
Knowledge-focused CompletedThis study looked at whether a computer analysis of liver biopsy images (called FibroNest Ph-FCS) can predict serious liver complications in people with a type of fatty liver disease called MASLD. Researchers reviewed data from 1,241 adults who had a liver biopsy and were followe…
Matched conditions: METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Sponsor: PharmaNest, Inc • Aim: Knowledge-focused
Last updated May 04, 2026 16:19 UTC